Lifecore Biomedical
LFCR
111 hedge funds and large institutions have $282M invested in Lifecore Biomedical in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 36 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
11% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 36
3% more funds holding
Funds holding: 108 → 111 (+3)
21% less capital invested
Capital invested by funds: $355M → $282M (-$73.6M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$2.87M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.56M |
| 3 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$2.29M |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$2.03M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$5.79M |
| 2 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
-$5.07M |
| 3 |
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
|
-$2.48M |
| 4 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$2.2M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$1.89M |
LFCR Hedge Fund Activity: Q3 2015 in Review
111 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q3 2015, worth a combined $282M — down 21% from $355M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new LFCR positions and 7 closed out — a net gain of 4 holders — while 40 added to existing stakes and 36 trimmed.
The largest buyer was Boston Partners, adding an estimated $2.87M. The largest seller was Guggenheim Capital, cutting an estimated $5.79M.
- 111 institutional investors held Lifecore Biomedical (LFCR) as of Q3 2015, up from 108 in Q2 2015.
- Funds reported $282M of Lifecore Biomedical stock for Q3 2015, down 21% quarter-over-quarter.
- 11 funds opened new Lifecore Biomedical positions in Q3 2015 and 7 closed out, a net change of +4 holders.
- The largest Lifecore Biomedical buyer in Q3 2015 was Boston Partners, an estimated $2.87M added.
- The largest Lifecore Biomedical seller in Q3 2015 was Guggenheim Capital, an estimated $5.79M sold.
Based on aggregated 13F filings for Q3 2015.